Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of the epidemiology, predictors, and management of atrial fibrillation in patients undergoing TAVI.
Atrial fibrillation (AF) is a common arrhythmia in patients with aortic stenosis. When these patients are treated medically or by surgical aortic valve replacement, AF is associated with increased risk of adverse events including death. Growing evidence suggests a significant impact of AF on outcomes also in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). Conversely, limited evidence is available regarding the optimal management of this condition. This review aims to summarize prevalence, pathophysiology, prognosis, and treatment of AF in patients undergoing TAVI.
No takes yet. Share an insight, caveat, or question.
Tarantini et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: